Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Diffuse Large B-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02889523
What this trial is testing

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

Who this might be right for
LymphomaDLBCLFollicular Lymphoma
The Lymphoma Academic Research Organisation 214
Post-approval studies (Phase 4)Study completedNCT00199082
What this trial is testing

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

Who this might be right for
Burkitt's LymphomaBurkitt's LeukemiaMediastinal Neoplasms+2 more
Nicola Goekbuget 650
Large-scale testing (Phase 3)UnknownNCT03018626
What this trial is testing

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Nanfang Hospital, Southern Medical University 402
Testing effectiveness (Phase 2)Study completedNCT00002471
What this trial is testing

Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04799275
What this trial is testing

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Who this might be right for
Ann Arbor Stage III Diffuse Large B-Cell LymphomaAnn Arbor Stage IIX (Bulky) Diffuse Large B-Cell LymphomaAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma+18 more
National Cancer Institute (NCI) 422
Early research (Phase 1)Active Not RecruitingNCT04850495
What this trial is testing

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaTransformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
Yazeed Sawalha 38
Testing effectiveness (Phase 2)Looking for participantsNCT06005870
What this trial is testing

Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression

Who this might be right for
Diffuse Large B Cell Lymphoma
Huazhong University of Science and Technology 41
Testing effectiveness (Phase 2)Looking for participantsNCT07749365
What this trial is testing

Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaPCNSL (Primary CNS Lymphoma)
The First Affiliated Hospital of Xiamen University 53
Not applicableStudy completedNCT01793233
What this trial is testing

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

Who this might be right for
Anaplastic Large Cell LymphomaBurkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more
Children's Oncology Group 203
Testing effectiveness (Phase 2)Study completedNCT03023878
What this trial is testing

Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma

Who this might be right for
High-risk Diffuse Large B-Cell Lymphoma
Amgen 47
Testing effectiveness (Phase 2)Looking for participantsNCT07371923
What this trial is testing

Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07588698
What this trial is testing

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)
Carrie Ho, MD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04978584
What this trial is testing

Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study

Who this might be right for
Diffuse Large B-Cell Lymphoma
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Looking for participantsNCT07499271
What this trial is testing

Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Testing effectiveness (Phase 2)Looking for participantsNCT07507318
What this trial is testing

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Who this might be right for
Diffuse Large B-Cell Lymphoma
Rong Tao 69
Testing effectiveness (Phase 2)Looking for participantsNCT06683885
What this trial is testing

A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Newly Diagnosed Diffuse Large B-cell Lymphoma
Mingzhi Zhang 80
Testing effectiveness (Phase 2)Study completedNCT03465527
What this trial is testing

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Kosin University Gospel Hospital 37
Early research (Phase 1)Not Yet RecruitingNCT07649304
What this trial is testing

AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")

Who this might be right for
AIDS-Related Diffuse Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements+6 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06925555
What this trial is testing

Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS

Who this might be right for
EBV-Positive Diffuse Large B-Cell Lymphoma, NosBrentuximab Vedotin
The First Affiliated Hospital with Nanjing Medical University 25
Next Page